July 30, 2020

Labcorp working with public health authorities on no-charge antibody test program to accelerate COVID-19 blood plasma donation

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 30, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced plans to create a program to offer total antibody testing at no charge through the patient’s doctor in support of increased blood plasma donations for use as a possible COVID-19 treatment.
Read more »

Labcorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation

Labcorp Announces 2020 Second Quarter Results